Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.65 |
| ▸ | MAG | P20916 | 8/20 | 0.59 |
| ▸ | SELP | P16109 | 2/20 | 0.56 |
| ▸ | SELL | P14151 | 1/20 | 0.56 |
| ▸ | SELE | P16581 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27398467 | 0.93 | SIGLEC7 (0.65) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL21134104 | 0.93 | SIGLEC7 (0.67) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL17950782 | 0.93 | SIGLEC7 (0.67) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL18966279 | 0.93 | SIGLEC7 (0.67) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL31701596 | 0.91 | SIGLEC7 (0.72) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL31700339 | 0.91 | SIGLEC7 (0.72) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL31701512 | 0.91 | SIGLEC7 (0.72) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL14268469 | 0.91 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL31701546 | 0.90 | SIGLEC7 (0.69) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL31700342 | 0.90 | SIGLEC7 (0.69) | SIGLEC7MAGSELPSELLSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8445239-B2 | Fermentation processes for cultivating streptococci and purification processes for obtaining CPS therefrom | NOVARTIS AG (CH) | 2013-05-21 | — | — | US | disclosed |
| US-20100272755-A1 | FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100272755-A1 | FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM | CPSF1, CPSF7, CPSF6 | SIGLEC7 241/4885MAG 996/4885SELP 1279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.